Yasmin is a contraceptive pill also prescribed in the treatment of moderate acne and premenstrual dysphoric disorder (PMDD) for menstruating women. Yasmin may also be sold under the brand name Yaz, a form of drospirenone manufactured and distributed by Bayer.
Yaz was the top-selling birth control pill in the US in 2008 and 2009, as it was marketed to treat women desperate for severe PMS and acne help. But independent studies involving a million women found that Yaz carries higher blood clotting risks than other leading birth control pills, leading to new scrutiny from safety regulators.
Bayer, the maker of the Yasmin contraceptive pill, has been reprimanded on several occasions because of questionable advertising campaigns–the ads were considered misleading in their promise to reduce or cure acne and help with PMS symptoms.
Yasmin has been reported to cause a variety of serious side effects since its FDA approval in May 2001. The more severe side effects of Yasmin may include:
- Blood clots
- Breast lumps
- Heart attack
- Hypertension (high blood pressure) and/or high cholesterol
- Kidney damage
- Liver damage (characterized by jaundice, stomach pain and/or dark urine)
- Pulmonary embolism (blood clots in the lung’s airways that significantly impair breathing and re-oxygenation of the blood)
Women developing any of the above conditions also experience some combination of the following symptoms:
- Abdominal pain
- Pain, swelling and/or sensitivity on a localized area of the skin (indicating a blood clot in that area)
- Feelings of despair and hopelessness
- Chest pain
- Confusion and disorientation
- Faintness and lightheadedness
- Breathing difficulties
- Numbness on one side of the body
- Vision problems (including blackened, blurry and/or double vision)
For a free legal consultation, call 800-285-4878
In March 2012, The Washington Monthly and the British Medical Journal(BMJ) reported the FDA advisory panel that voted 15-11 to keep Yaz, Yasmin and other drospirenone birth control drugs on the US market may have a conflict of interest. Four of the FDA panel members that voted in favor of keeping the drugs on the market had a connection with Bayer. Consumer advocacy groups, such as the Project on Government Oversight (POGO), are asking the FDA to re-open the issue about Yaz and Yasmin health risks and remove the four members from the panel.
Yaz, Yasmin and related drospirenone-containing pills were Bayer’s second-best-selling franchise in 2010 at $1.6 billion in global sales, according to the Associated Press.
Completed Intake Forms may be faxed to (469)484-7184, or returned via mail to: Loncar and Associates ATTN: YAZ 424 S. Cesar Chavez Blvd., Dallas, TX 75201 You may also call our office at (800)285-4878 for a postage-paid return envelope.